DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADB107113
Title:
Peripheral Neuropathy: Prevention and Treatment.
Corporate Author:
MICHIGAN UNIV ANN ARBOR
Report Date:
1984-07-31
Abstract:
Rats were dosed once daily with pyridostigmine 2 mgkg over a 20 day period. Groups of animals were assessed at intervals for changes in enzyme activity and nerve and muscle electrophysiologic activity. There was a marked inhibition of both acetylcholinesterase AChe and butyrylcholinesterase BuChE activity within 15 minutes of dosing. The activity recovered by 24 hours. There were no changes in nerve, spinal cord, or brain enzyme activity AChE, BuChE, neurotoxic esterase, carboxylesterase. Likewise, there were no changes in the compound action potential of either the sural or sciatic nerve and no changes in the sciatic nerve responsiveness to extracellular potassium. The triceps surae muscles responded normally to tetanic stimulation during the course of the experiment. Initial work has begun, using ALZET pumps to deliver constant infusions of either pyridostigmine or physostigmine.
Descriptive Note:
Annual summary rept. 15 Jul 83-14 Jul 84,
Pages:
0027
Distribution Statement:
Approved for public release, distribution unlimited.
Contract Number:
DAMD17-83-C-3187
File Size:
0.00MB
